The constitutive activation of NF-κB plays a crucial role in the development and chemoresistance of CRC through driving the expression of pro-proliferative/anti-apoptotic genes38,39, which can be further activated by chemotherapeutics10,38,40. The gene discussed is NFKB1; the disease is colorectal carcinoma.